WO2007125521A3 - Polymorphic form of zoledronic acid and processes for their preparation - Google Patents
Polymorphic form of zoledronic acid and processes for their preparation Download PDFInfo
- Publication number
- WO2007125521A3 WO2007125521A3 PCT/IB2007/051644 IB2007051644W WO2007125521A3 WO 2007125521 A3 WO2007125521 A3 WO 2007125521A3 IB 2007051644 W IB2007051644 W IB 2007051644W WO 2007125521 A3 WO2007125521 A3 WO 2007125521A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- zoledronic acid
- preparation
- processes
- polymorphic form
- amorphous
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
The present invention provides Form A and amorphous form of zoledronic acid. The present invention further provides processes for preparation of Form A, Form I and amorphous zoledronic acid. In addition the present invention provides pharmaceutical compositions comprising the polymorphic form and amorphous zoledronic acid.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1110DE2006 | 2006-05-02 | ||
IN1110/DEL/2006 | 2006-05-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2007125521A2 WO2007125521A2 (en) | 2007-11-08 |
WO2007125521A3 true WO2007125521A3 (en) | 2008-01-10 |
Family
ID=38332422
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2007/051644 WO2007125521A2 (en) | 2006-05-02 | 2007-05-02 | Polymorphic form of zoledronic acid and processes for their preparation |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2007125521A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071574B2 (en) | 2005-02-22 | 2011-12-06 | John Dennis Bobyn | Implant improving local bone formation |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1925621A1 (en) * | 2006-11-27 | 2008-05-28 | Novartis AG | Crystalline forms of zoledronic acid |
KR101813728B1 (en) | 2009-07-31 | 2017-12-29 | 그뤼넨탈 게엠베하 | Crystallization method and bioavailability |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US9340565B2 (en) | 2010-11-24 | 2016-05-17 | Thar Pharmaceuticals, Inc. | Crystalline forms |
US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4939130A (en) * | 1986-11-21 | 1990-07-03 | Ciba-Geigy Corporation | Substituted alkanediphosphonic acids and pharmaceutical use |
WO2003093282A1 (en) * | 2002-04-29 | 2003-11-13 | Chemi S.P.A. | Preparation of biphosphonic acids and salts thereof |
US20040043967A1 (en) * | 2002-05-17 | 2004-03-04 | Rami Lidor-Hadas | Novel process for making bisphosphonic acids using diluents other than halogenated hydrocarbons |
WO2004075860A2 (en) * | 2003-02-27 | 2004-09-10 | Teva Pharmaceutical Industries Ltd. | Process for purification of zoledronic acid |
US20050054616A1 (en) * | 2003-07-03 | 2005-03-10 | Judith Aronhime | Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
WO2005044831A2 (en) * | 2003-08-21 | 2005-05-19 | Sun Pharmaceutical Industries Limited | A process for preparation of bisphosphonic acid compounds |
WO2005063779A2 (en) * | 2003-12-23 | 2005-07-14 | Lyogen Limited | A process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof |
WO2005063717A1 (en) * | 2003-12-26 | 2005-07-14 | Natco Pharma Limited | An improved process for the preparation of zoledronic acid |
WO2005066188A1 (en) * | 2003-10-17 | 2005-07-21 | Sun Pharmaceutical Industries Limited | A process for the preparation of 2-(imidazol-1-yl)-1-hydroxyethane-1, 1-diphosphonic acid |
CN1693308A (en) * | 2005-04-15 | 2005-11-09 | 扬子江药业集团有限公司 | Process for preparing dazoline phospho acid |
US20060258625A1 (en) * | 2006-02-20 | 2006-11-16 | Alembic Limited | Process for the preparation of biphosphonic derivatives |
WO2006134603A1 (en) * | 2005-06-13 | 2006-12-21 | Jubilant Organosys Limited | Process for producing bisphosphonic acids and forms thereof |
WO2007016982A1 (en) * | 2005-07-28 | 2007-02-15 | Gador S.A. | A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it |
WO2007032808A1 (en) * | 2005-09-12 | 2007-03-22 | Dr. Reddy's Laboratories Ltd. | Crystalline trihydrate of zoledronic acid |
WO2007069049A2 (en) * | 2005-12-16 | 2007-06-21 | Wockhardt Ltd | Processes for the preparation of pure zoledronic acid |
-
2007
- 2007-05-02 WO PCT/IB2007/051644 patent/WO2007125521A2/en active Application Filing
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4939130A (en) * | 1986-11-21 | 1990-07-03 | Ciba-Geigy Corporation | Substituted alkanediphosphonic acids and pharmaceutical use |
WO2003093282A1 (en) * | 2002-04-29 | 2003-11-13 | Chemi S.P.A. | Preparation of biphosphonic acids and salts thereof |
US20040043967A1 (en) * | 2002-05-17 | 2004-03-04 | Rami Lidor-Hadas | Novel process for making bisphosphonic acids using diluents other than halogenated hydrocarbons |
WO2004075860A2 (en) * | 2003-02-27 | 2004-09-10 | Teva Pharmaceutical Industries Ltd. | Process for purification of zoledronic acid |
US20050054616A1 (en) * | 2003-07-03 | 2005-03-10 | Judith Aronhime | Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
WO2005044831A2 (en) * | 2003-08-21 | 2005-05-19 | Sun Pharmaceutical Industries Limited | A process for preparation of bisphosphonic acid compounds |
WO2005066188A1 (en) * | 2003-10-17 | 2005-07-21 | Sun Pharmaceutical Industries Limited | A process for the preparation of 2-(imidazol-1-yl)-1-hydroxyethane-1, 1-diphosphonic acid |
WO2005063779A2 (en) * | 2003-12-23 | 2005-07-14 | Lyogen Limited | A process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof |
WO2005063717A1 (en) * | 2003-12-26 | 2005-07-14 | Natco Pharma Limited | An improved process for the preparation of zoledronic acid |
CN1693308A (en) * | 2005-04-15 | 2005-11-09 | 扬子江药业集团有限公司 | Process for preparing dazoline phospho acid |
WO2006134603A1 (en) * | 2005-06-13 | 2006-12-21 | Jubilant Organosys Limited | Process for producing bisphosphonic acids and forms thereof |
WO2007016982A1 (en) * | 2005-07-28 | 2007-02-15 | Gador S.A. | A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it |
WO2007032808A1 (en) * | 2005-09-12 | 2007-03-22 | Dr. Reddy's Laboratories Ltd. | Crystalline trihydrate of zoledronic acid |
WO2007069049A2 (en) * | 2005-12-16 | 2007-06-21 | Wockhardt Ltd | Processes for the preparation of pure zoledronic acid |
US20060258625A1 (en) * | 2006-02-20 | 2006-11-16 | Alembic Limited | Process for the preparation of biphosphonic derivatives |
Non-Patent Citations (3)
Title |
---|
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; CAI, WEI ET AL: "Preparation of zoledronic acid from imidazole", XP002447128, retrieved from STN Database accession no. 2006:708301 * |
SANDERS, JOHN M. ET AL: "3-D QSAR Investigations of the Inhibition of Leishmania major Farnesyl Pyrophosphate Synthase by Bisphosphonates", JOURNAL OF MEDICINAL CHEMISTRY , 46(24), 5171-5183 CODEN: JMCMAR; ISSN: 0022-2623, 2003, XP002447558 * |
ZHU J ET AL: "SYNTHESIS OF ZOLEDRONIC ACID", ZHONGGUO XIN YAO ZAZHI - CHINESE NEW DRUGS JOURNAL, GAI-KAN BIANJIBU, BEIJING, CN, vol. 12, no. 1, January 2003 (2003-01-01), pages 39 - 40, XP001204255, ISSN: 1003-3734 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071574B2 (en) | 2005-02-22 | 2011-12-06 | John Dennis Bobyn | Implant improving local bone formation |
Also Published As
Publication number | Publication date |
---|---|
WO2007125521A2 (en) | 2007-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2013257508A1 (en) | Pharmaceutical compositions | |
WO2007127834A3 (en) | Compositions and methods of preparation thereof | |
AU2007299727A8 (en) | Self preserved aqueous pharmaceutical compositions | |
WO2006023627A8 (en) | Rapamycin polymorph ii and uses thereof | |
WO2009025876A8 (en) | Crystalline forms of erlotinib hcl and formulations thereof | |
WO2010049454A3 (en) | Antimicrobial composition from copepods | |
ZA200800729B (en) | A crystalline form of the zoledronic acid, a process to obtain it and the pharmaceutical composition comprising it | |
WO2008083130A3 (en) | Amorphous and crystalline form a of carvedilol phosphate | |
WO2008027600A3 (en) | Imatinib compositions | |
IL190880A (en) | Crystalline fusidic acid, method for its preparation and pharmaceutical composition comprising it | |
WO2007067784A3 (en) | Liposomal compositions | |
WO2008129501A3 (en) | Pharmaceutical compositions of duloxetine | |
WO2007125521A3 (en) | Polymorphic form of zoledronic acid and processes for their preparation | |
WO2008001201A3 (en) | Pharmaceutical compositions of clopidogrel | |
WO2008088779A3 (en) | Solid state forms of 5-azacytidine and processes for preparation thereof | |
WO2009100275A3 (en) | Compositions and devices | |
WO2010008735A3 (en) | Solid states of o-desmethylvenlaf axine salts | |
WO2008051564A3 (en) | Crystalline forms of palonosetron hydrochloride | |
WO2009002538A3 (en) | Amorphous erlotinib, processes for the preparation thereof, and processes to prepare additional forms of erlotinib | |
WO2008137134A3 (en) | Amorphous eletriptan hydrobromide and process for preparing it and other forms of eletriptan hydrobromide | |
WO2008073863A3 (en) | Preparation and utility of substituted allylamines | |
WO2009102707A3 (en) | Substituted oxazaphosphorines | |
PL2231598T3 (en) | Novel diazeniumdiolate derivatives, method for the preparation thereof and pharmaceutical compositions containing the same | |
WO2007098273A3 (en) | Novel crystalline forms of armodafinil and preparation thereof | |
WO2008019782A3 (en) | Dispersions of nanoureas containing active ingredients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07735743 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 07735743 Country of ref document: EP Kind code of ref document: A2 |